Retatrutide
TRIUMPH-1
Eli Lilly · Phase 3 · Completed · Enrollment 2335
Y axis: Change in body weight from baseline, %
X axis: Weeks since randomization
Cited trial source. Only weeks the source states.
- retatrutide 4 mg, one timepoint
- retatrutide 9 mg, one timepoint
- retatrutide 12 mg, one timepoint
- Placebo, one timepoint
- retatrutide 4 mg: week 80 -17.6%
- retatrutide 9 mg: week 80 -23.7%
- retatrutide 12 mg: week 80 -25%
- Placebo: week 80 -3.9%
One reported week is a point at that week. It is not a line from 0%. A solid line connects two or more reported weeks.